Jazz Pharmaceuticals PLC (JAZZ) — Cash Flow-to-Debt Ratio
Jazz Pharmaceuticals PLC (JAZZ) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $408.20 Million could theoretically repay 0% of its total liabilities ($7.33 Billion) in one year. See how financially flexible is Jazz Pharmaceuticals PLC to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jazz Pharmaceuticals PLC Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Jazz Pharmaceuticals PLC across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Jazz Pharmaceuticals PLC.
Annual Cash Flow-to-Debt Ratio for Jazz Pharmaceuticals PLC (2005–2025)
Year-by-year debt coverage analysis for Jazz Pharmaceuticals PLC. Check JAZZ cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $1.36 Billion | $7.34 Billion | ▲ +4.8% |
| 2024 | 0.18x | $1.40 Billion | $7.92 Billion | ▲ +23.6% |
| 2023 | 0.14x | $1.09 Billion | $7.66 Billion | ▼ -13.1% |
| 2022 | 0.16x | $1.27 Billion | $7.75 Billion | ▲ +75.7% |
| 2021 | 0.09x | $778.51 Million | $8.33 Billion | ▼ -70.1% |
| 2020 | 0.31x | $899.65 Million | $2.88 Billion | ▼ -2.2% |
| 2019 | 0.32x | $776.40 Million | $2.43 Billion | ▼ -2.1% |
| 2018 | 0.33x | $798.90 Million | $2.45 Billion | ▲ +13.6% |
| 2017 | 0.29x | $693.09 Million | $2.41 Billion | ▲ +42.3% |
| 2016 | 0.20x | $590.54 Million | $2.92 Billion | ▼ -33.1% |
| 2015 | 0.30x | $531.94 Million | $1.76 Billion | ▲ +46.5% |
| 2014 | 0.21x | $405.76 Million | $1.97 Billion | ▼ -31.5% |
| 2013 | 0.30x | $283.62 Million | $942.69 Million | ▲ +1.8% |
| 2012 | 0.30x | $249.75 Million | $845.20 Million | ▼ -88.2% |
| 2011 | 2.49x | $151.60 Million | $60.78 Million | ▲ +345.6% |
| 2010 | 0.56x | $58.87 Million | $105.18 Million | ▲ +735.3% |
| 2009 | -0.09x | $-15.88 Million | $180.23 Million | ▲ +85.8% |
| 2008 | -0.62x | $-130.23 Million | $210.38 Million | ▼ -16.5% |
| 2007 | -0.53x | $-81.09 Million | $152.56 Million | ▼ -262.3% |
| 2006 | -0.15x | $-57.35 Million | $390.87 Million | ▲ +20.4% |
| 2005 | -0.18x | $-52.16 Million | $283.03 Million | — |